| Literature DB >> 35945580 |
Mwila Ng'andu1, Aldina Mesic2, Jake Pry3, Chanda Mwamba3, Florence Roff4, Jenala Chipungu3, Yael Azgad4, Anjali Sharma3,2.
Abstract
BACKGROUND: The COVID-19 pandemic could worsen adolescent sexual and reproductive health (ASRH). We sought evidence on the indirect impacts of previous infectious disease epidemics and the current COVID-19 pandemic on the uptake of ASRH in sub-Saharan Africa (SSA) to design relevant digital solutions.Entities:
Keywords: Access; Adolescents; COVID-19; Ebola; Epidemics; Family planning; Maternal health; Utilization; Young people
Mesh:
Year: 2022 PMID: 35945580 PMCID: PMC9361234 DOI: 10.1186/s13643-022-02035-x
Source DB: PubMed Journal: Syst Rev ISSN: 2046-4053
Search termsa
| Population | Adolescents, young people, adults, general population |
|---|---|
| Concept | Reproductive, sexual, contraception, family planning, contraceptive, HIV service, HIV testing, HIV program, HIV treatment, antiretroviral therapy, abortion, sexually transmitted infections, sexually transmitted diseases, morning after pill, emergency, cervical cancer screening |
| Context | Pandemic, epidemic, outbreak, COVID, COVID-19, coronavirus, Severe Acute Respiratory Syndrome Coronavirus-2 OR SARS-CoV-2.b,c |
aThe full search string included all variations of the search terms and associated acronyms
bThe focus of this review was initially on adolescents and young people, but given very few relevant studies, the population was broadened
cWe expected all relevant outbreaks (e.g., cholera, Ebola) but would be captured with terms such as “pandemic”, “epidemic” and “outbreak”
Scoping inclusion and exclusion criteria
| Criteria | Inclusion | Exclusion criteria |
|---|---|---|
| Publication type | Peer Reviewed; full text available through a library service | Not Peer Reviewed; full-text not accessible |
| Language | English | Non-English |
| Setting/place | Sub-Saharan Africaa | Not sub-Saharan Africa |
| Study design/type | Any studies with primary data (i.e., observational studies, randomized controlled trials, qualitative studies) | Commentaries; systematic reviews; meta-analyses; scoping reviews; modeling studies |
| Time limit | Any time | None |
aAccording to the World Bank, sub-Saharan Africa includes the following countries: Angola, Benin, Botswana, Burkina Faso, Burundi, Cameroon, Central African Republic, Chad, Congo, Cote d'Ivoire, Eritrea, Ethiopia, Gabon, Gambia, Ghana, Guinea, Guinea-Bissau, Kenya, Lesotho, Liberia, Madagascar, Malawi, Mali, Mauritania, Mauritius, Mozambique, Namibia, Niger, Nigeria, Rwanda, Senegal, Sierra Leone, Somalia, South Africa, United Republic of Tanzania, Togo, Uganda, Zaire, Zambia, and Zimbabwe
Fig. 1PRISMA study selection procedure flow chart
Description of studies included in the scoping review (N = 21)
| Variable | Number of studies (%) |
|---|---|
| Sub-Saharan African countries | |
| Ethiopia | 1 (4.8%) |
| Guinea | 5 (23.8%) |
| Kenya | 2 (9.5%) |
| Liberia | 9 (42.9%) |
| Nigeria | 1 (4.8%) |
| Sierra Leone | 6 (25.6%) |
| South Africa | 1 (4.8%) |
| Type of data collected | |
| Quantitative | 16 (76.2%) |
| Qualitative | 2 (9.6%) |
| Mixed methods/multi-methods | 3 (14.3%) |
| Type of study | |
| Observational | 21 (100%) |
| Year of publication | |
| 2015 | 6 (28.6%) |
| 2016 | 2 (9.5%) |
| 2017 | 5 (23.8%) |
| 2018 | 1 (4.8%) |
| 2019 | 2 (9.5%) |
| 2020 | 5 (23.8%) |
| Pandemic | |
| Ebola | 18 (85.7%) |
| COVID-19 | 3 (14.3%) |
| Sexual reproductive health outcomesa | |
| Labor and delivery (L&D) | 13 (61.9%) |
| Family planning (FP) | 8 (38.1%) |
| Antenatal care (ANC) | 7 (33.3%) |
| HIV | 6 (28.6%) |
| Maternal mortality (MM) | 4 (19%) |
| Condoms | 1 (4.8%) |
| Adolescents and young people (AYP) | 1 (4.8%) |
aOnly quantitative studies (n = 18) are included
Studies on SRH care during pandemics included in the scoping review (n = 21)a
| Study | Epidemic; location | Population/setting | Type of data collected; period of data collection | Sexual reproductive health outcomes |
|---|---|---|---|---|
| Abdela, 2020 [ | COVID-19; Dessie town, South Wollo Zone, Ethiopia | Dessie referral hospital | Facility registers February 2–April 19, 2020 | FP, ANC, L&D |
| Bietsch, 2020 [ | Ebola; Liberia and Sierra Leone | Facility-level service statistics; DHS data | Pre-Ebola 2013 DHS data; service statistics quantitative electronic routine facility-level data; Survey data from Multiple Indicator Cluster Survey (MICS) 6 months before the first Ebola case and 37 months after last case of main outbreak in Liberia and Sierra Leone | FP, Condoms |
| Brolin Ribacke, 2016 [ | Ebola; Sierra Leone | 32 government, private, not- and for-profit healthcare facilities offering emergency obstetrics | Facility surveys and service-statistics captured using DHIS 2; Three periods between January 2014-May 2015: Pre-outbreak period (week 1–21, 2014), outbreak peak (week 22–52, 2014), and outbreak slow down (week 1–20 2015) | L&D |
| Camara, 2017 [ | Ebola; Macenta District, Guinea | 187,094 women of reproductive age (15-45 years) | Facility-level data Pre-Ebola (March 1, 2013- February 28th, 2014), intra-Ebola (March 1, 2014 to February 28th, 2015) and post-Ebola (March 1, 2016 to July 31, 2016) | L&D, ANC, MM |
| Delamou, 2017 [ | Ebola; six districts in the Forest Region of Guinea | One regional hospital, five district referral hospitals, two community hospitals, 38 health centers, serving 1,747,4000 people | Facility-level data Pre-Ebola (January 2013- February 2014), during-Ebola (March 2014–February 2015) and post-Ebola (March 2015–February 2016). | L&D, ANC, AYP |
| Iyengar, 2015 [ | Ebola; Margibi County and Bong County, Liberia | 75 primary healthcare facilities in Margibi and Bond Counties | Service statistics from routine electronic facility-level DHIS-2 March–December 2014 | L&D, FP |
| Jacobs, 2017 [ | Ebola; Liberia | All individuals > 15 years included in the DHIS-2 | Service statistics from routine electronic facility-level DHIS-2 Pre-Ebola (2013), during Ebola (2014), and post-Ebola (2015) | HIV |
| Jones, 2016 [ | Ebola; Sierra Leone | 13 comprehensive and 67 basic health care facilities across 13 districts | Data collected via facility surveys and facility registers | L&D, ANC, MM |
| Konwloh, 2017 [ | Ebola; Liberia | All patients in Liberia with presumptive and active TB that were investigated, diagnosed, or treated between 2013 and 2015 | Pre-Ebola (January 2013–March 2014), during Ebola (April 2014–June 2015) and post-Ebola (July–December 2015). Facility-level service statistics from DHIS2 | HIV |
| Leuenberger, 2015 [ | Ebola; Macenta District in the Forest Region of Guinea | Centre Medical, a specialized hospital, the only HIV care facility in the district | Routine and prospective facility-level data for hospital planning and reporting to health authorities; internal accountancy data, and data collected as part of the International epidemiological Databases to Evaluate AIDS (IeDEA) West Africa collaboration During Ebola (August–December 2014) and Pre-Ebola (August–December 2013) For retention in care, data was collected for a longer period (first semesters of 2013 and 2014 before Ebola) | HIV |
| Lori, 2015 [ | Ebola; Bong County, Liberia | 12 study sites from Bong County | Facility-level January 2012–October 2014 | L&D |
| Loubet, 2015 [ | Ebola; Liberia | 5948 patients across two hospitals, John F. Kennedy and Redemption Hospital | Facility-level data Pre-Ebola (January 2012 to June 2014); point break to indicate during Ebola (June–November 2014) | HIV |
| Ly, 2016 [ | Ebola; Rivercess County, Liberia | 1,298 women from 941 households | Household survey Pre-Ebola (March 24, 2011–June 14, 2014), during Ebola (June 15, 2014–April 13, 2015) | L&D |
| McQuilkin, 2017 [ | Ebola; 15 counties in Liberia | 543 households were cluster sampled from catchment areas of 21 government hospitals | Household structured questionnaires March–May 2015 | L&D, FP |
| Miller, 2018 a [ | Ebola; Guinea (Dubréka, Forécariah, Macenta and Kérouané Districts), Liberia (Lofa, Montserrado, Margibi, and Bong), and Sierra Leone (Kenema, Kailahun, Bombali, and Tonkolili) | 582 participants from the MoH UN agencies, iNGOs, NGOs, traditional healers, community leaders, caregivers of children under five, CHWs, TBAs, officers in charge of health facilities, MCH aides, members of CHCs and EVD survivors selected using purposive non-probability sampling | Routine program data from the MoH and NGO implementing partners January 2013 to December 2015 In-depth interviews and focus group discussions February–August 2016 (Liberia: February–March; Sierra Leone: May–June; Guinea; July–August) | |
| Quaglio, 2019 [ | Ebola; Pujehun district, Sierra Leone | 77 community health facilities and one hospital | Routine facility-level health services data Pre-Ebola (January 1, 2012–May 30, 2014), Ebola (June 1, 2014–February 28, 2015), Post-Ebola (March 1, 2015–December 31, 2017) | L&D, FP, ANC |
| Siedner, 2020 [ | COVID-19; uMkhanyakude district, Kwa-Zulu Natal, South Africa | 46,523 across 11 primary care clinics | Routine health facility data from HDSS and AHRI Pre-lockdown (January 27–March 27, 2020), level 5c lockdown (March 28, 2020–April 30, 2020), level 4c lockdown May 1-31, level 3c lockdown until data abstraction date (June 1-30). | FP, ANC |
| Barden-O'Fallon, 2015 [ | Ebola; All four geographic zones of Guinea (Upper, Lower, Middle, and Forest) | A convenience sample of 16 hospitals and 29 health centers that were categorized as “active”; “calm” and “not affected” in relation to Ebola cases; 62 health service directors; 117 RMNCH providers | Retrospective quantitative facility-level data collected from October 2013–December 2014 (categorized as Ebola Active, Changing Status, or Inactive) Brief structured qualitative interviews January-February 2015.b | L&D, FP, HIV, MM |
| Ahmed, 2020 [ | COVID-19; Seven slums in Nigeria, Kenya, Pakistan, and Bangladesh; | Qualitative data from individual discussions (20–50 min) and group discussions (1–3 h). Pre-COVID (March 2018–March 2020), as part of the | L&D, HIV | |
| Elston, 2016a [ | Ebola; Moyamba District in the Southern Region and Koinadugu District in the Northern Region, Sierra Leone | 60 stakeholders including Ebola response teams, civil/transition authority, healthcare workers, members of NGOs, community members, a women’s group, mothers with children attending a child health clinic, social mobilizers and town council members 15 purposively selected health facilities in Moyamba | Interviews with 60 stakeholders Focus group discussions February and May 2015.b | |
| Gichuna, 2020 a [ | COVID-19; Nairobi, Kenya | 117 female sex workers 15 healthcare providers | Semi-structured interviews (15–20 min) over mobile phones April–May 2020. |
aAcronyms in Table 4: AHRI Africa Health Research Institute, AYP Adolescents and Young People, CHC Community Health Center, CHW Community Health Worker, DHIS2 District Health Information Software, DHS Demographic Health Survey, EVD Ebola Virus disease, FP Family Planning, HDSS Health Demographic Surveillance System, L&D Labor and Delivery, iNGO international non-governmental agency, IPTp Intermittent Preventive Therapy for Malaria, MM Maternal Mortality, MoH Ministry of Health, NGO non-governmental agency, PNC Prenatal care, ANC antenatal care, RMNCH reproductive, maternal, newborn and child health, SHRH Sexual Health Reproductive Health, TBA Traditional Birth Attendant, TT2 tetanus toxoid, UN: United Nations
bFindings not reported by outcome area for qualitative studies
cIn South Africa, a level 5 order is considered a shelter in place order which includes closure of schools and non-essential businesses and restrictions on movement and public transportation. Residents were instructed to remain in their homes unless they were “performing an essential service, obtaining an essential good, or seeking emergency, lifesaving, or chronic care.” At the end of April, South Africa moved to level 4, then level 3 which lifted several restrictions. Level 4 allowed for some businesses and transportation to open. Level 3 included the opening of many establishments (e.g., cinemas, restaurants, gyms) and increased access to local and long-distance travel
Summary of quantitative and qualitative barriers and facilitators affecting SRH utilization and access during pandemics (n = 7)
| Barriers | Facilitators |
|---|---|
| Increased cost of medicines and supplies | Resources to alleviate travel difficulties |
| Difficulty traveling and long distance from facilities | Alternative modes of care delivery |
| Fear of infection from health facilities | |
| Lack trust in health system or quality of care provision | |
| Demographic factors such as not being educated | |
| Supply side issues including closure of health facilities, lack of workers, services, and supplies | |
| Stigma associated with infection |
Fig. 2Recommendations for improving AYP health during pandemics within the Donabedian model